Annual Drug Patent Expirations for LILETTA Liletta is a drug marketed by Medicines360 and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie and is included in one NDA. It […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Denmark. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Denmark? Read Post »
The biotechnology sector continued to showcase its dynamic nature this week, with groundbreaking discoveries and innovative approaches making headlines across
Biotechnology Week in Review: June 30 – July 5, 2024 Read Post »
The biologics industry has witnessed significant advancements in recent years, with the introduction of biosimilars offering a more affordable and
Introduction Infectious diseases have been a significant threat to human health for centuries. The rapid spread of diseases such as
The Role of Biotechnology in Infectious Disease Control Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most gas dosed drugs. For a different perspective, see the most popular […]
Source
Which pharmaceutical companies have the most gas dosed drugs? Read Post »
Understanding the Crucial Role of Excipients in Drug Development For those new to pharmaceutical formulation, the world of excipients can seem daunting. These “inactive” ingredients play a critical role in drug development, affecting everyt…
Excipient Selection: Expert Tips for Pharmaceutical Formulation Novices Read Post »
Get new actionable insights and updates from BiotechBlog
